This one of a kind mechanism induces a synergistic effect with Increased insulin reaction and glucagonostatic action, compared to GIP or GLP-one therapy alone. Abstract Tirzepatide is a fresh molecule effective at managing glucose blood amounts by combining the twin agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-one (GLP-1) https://remingtonbsidv.ka-blogs.com/81391067/article-under-review